D-0876-2023 Class II Terminated
FDA drug recall D-0876-2023 was initiated by Amneal Pharmaceuticals Of New York, LLC on May 30, 2023 and is designated Class II. Reason for recall: Failed Dissolution Specifications: Out-of-specification results for dissolution (above specification) The recall status is terminated (terminated Jun 10, 2025). Affected quantity: 9,056 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 21, 2023
- Initiation Date
- May 30, 2023
- Termination Date
- Jun 10, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 9,056 bottles
Product description
Extended Phenytoin Sodium Capsules, USP, 100 mg, Rx Only, 100 capsules per bottle, Distributed by: Amneal Pharmaceuticals LLC., Bridgewater, NJ 08807, NDC 65162-212-10.
Reason for recall
Failed Dissolution Specifications: Out-of-specification results for dissolution (above specification)
Distribution pattern
LA, PA and OH.
Code information
Lot # HL00721A, Exp. 12/2023
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0876-2023
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026